Found 96 matching trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies PHASE1 The goal of this clinical research study is to learn if it is safe and feas...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Personalized NK Cell Therapy in CBT PHASE2 This phase II clinical trial studies how well personalized natural killer (...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Allogeneic Transplant in HIV Patients (BMT CTN 0903) PHASE2 The rationale for this trial is to demonstrate the feasibility and safety o...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) PHASE2 This trial is looking at using umbilical cord blood from unrelated donors a...
Show More Location
University College London Hospital
Learn More & Join Trial
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant PHASE1 This phase I trial tests the safety, side effects and effectiveness of emap...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant PHASE2 RATIONALE: Giving low doses of chemotherapy, monoclonal antibodies, and rad...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases PHASE2 RATIONALE: Umbilical cord blood transplantation may be able to replace immu...
Show More Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Learn More & Join Trial